【摘 要】
：
Recent studies show that intracellular accumulation of cholesterol leads to acquired resistance to gefitinib in non-small cell lung cancer(NSCLC)cells.In this study we investigated how to regulate the cholesterol levels in gefitinib-resistant NSCLC cells.
【机 构】
：
School of Basic Medicine and Clinical Pharmacy,China Pharmaceutical University,Nanjing 210009,China;
论文部分内容阅读
Recent studies show that intracellular accumulation of cholesterol leads to acquired resistance to gefitinib in non-small cell lung cancer(NSCLC)cells.In this study we investigated how to regulate the cholesterol levels in gefitinib-resistant NSCLC cells.We showed that intracellular cholesterol levels in gefitinib-resistant cell lines(PC-9/GR,H1975,H1650,and A549)were significantly higher than that in gefitinib-sensitive cell line(PC-9).Treatment with gefitinib(5 μM)significantly increased intracellular cholesterol levels in PC-9/GR,H1 975,and H1650 cells.Gefitinib treatment downregulated the expression of PPARα,LXRα,and ABCA1,leading to dysregulation of cholesterol efflux pathway.We found that a lipid-lowering drug fenofibrate(20,40 μM)dose-dependently increased the expression of PPARα,LXRα,and ABCA1,decreased the intracellular cholesterol levels,and enhanced the antiproliferative effects of gefitinib in PC-9/GR,H1 975,and H1650 cells.We revealed that fenofibrate increased the gefitinib-induced apoptosis via regulating the key proteins involved in the intrinsic apoptosis pathway.In PC-9/GR,H1975 and H1650 cells,fenofibrate dose-dependently increased the expression of AMPK,FoxO1,and decreased the expression of AKT,which were remarkably weakened by knockdown of PPARα.In PC-9/GR cell xenograft mice,combined administration of gefitinib(25 mg·kg-1·d-1)and fenofibrate(100 mg·kg-1·d-1)caused remarkable inhibition on tumor growth as compared to treatment with either drug alone.All the results suggest that fenofibrate relieves acquired resistance to gefitinib in NSCLC by promoting apoptosis via regulating PPARα/AMPK/AKT/FoxO1 pathway.We propose that combination of gefitinib and fenofibrate is a potential strategy for overcoming the gefitinib resistance in NSCLC.
其他文献
Our previous study showed that chronic treatment with tumor necrosis factor-α(TNF-α)decreased cAMP concentration in fibroblast-like synoviocytes(FLSs)of collagen-induced arthritis(CIA)rats.In this study we investigated how TNF-α impairs cAMP homeostasis,p
N-n-Butyl haloperidol iodide(F2)is a novel compound that has antiproliferative and antifibrogenic activities.In this study we investigated the therapeutic potential of F2 against liver fibrosis in mice and the underlying mechanisms.Two widely used mouse m
Mifepristone(Mif),an effective synthetic steroidal antiprogesterone drug,is widely used for medical abortion and pregnancy prevention.Due to its anti-glucocorticoid effect,high-dose Mif is also used to treat Cushing\'s syndrome.Mif was reported to activ
Oxidative stress-related cartilage degeneration,synovitis,and joint pain play vital roles in the progress of osteoarthritis(OA).Anti-oxidative stress agents not only prevent structural damage progression but also relieve OA-related pain.In this study,we i
EIDD-2801 is an orally bioavailable prodrug,which will be applied for emergency use autho-rization from the U.S.Food and Drug Administration for the treatment of COVID-19.To investigate the optimal parameters,EIDD-2801 was optimized via a four-step synthe
Coronavirus disease 2019(COVID-19)broke out in December 2019.Due its high morbility and mortality,it is necessary to summarize the clinical characteristics of COVID-19 patients to provide more theoretical basis for future treatment.In the current study,we
Programmed death ligand-1(PD-L1)/PD-1 checkpoint extensively serves as a central mediator of immunosuppression.A tumor-promoting role for abundant PD-L1 in several cancers is revealed.However,the importance of PD-L1 and how the PD-L1 expression is control
Long noncoding RNAs(IncRNAs)are involved in a variety of cancers,but the role of LncRNA DUBR in lung adenocarcinoma(LUAD),the most prevalent form of lung cancer,remains unclear.In this study we investigated the expression of DUBR in LUAD to ascertain its
目的 血管内皮细胞是机体最大的内分泌组织细胞,位于血流与血管壁之间,将血液与血管壁分离开来.血管内皮细胞通过合成和释放多种内皮源性舒张因子和收缩因子在调节血管张力方面发挥着重要作用.此外,内皮细胞在维持抗凝/促凝平衡、血管生成、内分泌以及炎症和免疫中的作用也越来越被重视.越来越多的证据表明,血管内皮细胞功能对血管内稳态的维持至关重要,血管内皮细胞功能障碍是与血管收缩、血栓形成和炎症状态有关的各种微血管病变相关疾病的共同标志.本文主要就血管内皮细胞的结构和功能,以及功能障碍在心血管疾病、糖尿病并发症、慢性肾
Acidosis,regardless of hypoxia involvement,is recognized as a chronic and harsh tumor microenvironment(TME)that educates malignant cells to thrive and metastasize.Although over-whelming evidence supports an acidic environment as a driver or ubiquitous hal